| Literature DB >> 35041067 |
Tim M Klabbers1,2, Floris Heutink3,4, Wendy J Huinck3,4, Willem-Jan van der Woude5, Berit M Verbist5,6, Emmanuel A M Mylanus3,4.
Abstract
PURPOSE: The aim of this study was to evaluate the intracochlear position of the Slim Modiolar Electrode (SME) after insertion via the extended Round Window (eRW) approach, and to correlate this with residual hearing preservation and speech perception outcomes.Entities:
Keywords: Cochlear implantation; Extended round window approach; Residual hearing; Slim modiolar electrode
Mesh:
Year: 2022 PMID: 35041067 PMCID: PMC9474433 DOI: 10.1007/s00405-021-07247-w
Source DB: PubMed Journal: Eur Arch Otorhinolaryngol ISSN: 0937-4477 Impact factor: 3.236
Fig. 1Intraoperative view of the round window of a right ear through the facial recess after completion of the cortical mastoidectomy and posterior tympanotomy. A Before antero-inferior drilling and B after antero-inferior drilling. FN facial nerve, RW round window, TW tissue wipe, CT chorda tympani nerve
Fig. 2Mid-modiolar section of the post-implantation UHRCT of participant #12 indicating scala tympani placement of the electrode array
Audiometric data
| ID | Gender | Age | Etiology | CI side | Tip fold-over | Scalar location | LFPTA (in dB) | 2-month RHP | 12-month RHP | Postoperative speech recognition (CVC-phoneme scores) | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| preLFPTA CI ear (dB) | preLFPTA CL ear (dB) | Δ LFPTAa CI ear (dB) | Δ LFPTA CL ear (dB) | % | Cat | % | Cat | Pre-operative | 2 months | 12 months | |||||||
| 1b | M | 28 | Mitochondropathy | R | N | ST | 66.7 | CI | 45 | CI | 0% | M | 0% | M | 56 | 59 | 56 |
| 2 | F | 60 | Hereditary | R | N | ST | 70 | 70 | 5 | – 5 | 88% | C | 60% | P | 39 | 90 | 87 |
| 3 | M | 70 | Usher IIa | R | N | ST | 98.3 | 98.3 | 13.4 | – 6.7 | 0% | M | 0% | M | 18 | 48 | 79 |
| 4 | F | 70 | Unknown | R | N | ST | 80 | 56.7 | 18.3 | 0 | 42% | P | – | – | 24 | 73 | 87 |
| 5 | F | 61 | Unknown | R | N | ST | 75 | 88.3 | 8,3 | – 3.3 | 77% | C | 77% | C | 27 | 50 | 66 |
| 6 | F | 65 | Unknown | L | N | ST | 90 | 48.3 | 6.7 | 6.7 | 69% | P | 53% | P | - | 69 | 90 |
| 7 | F | 69 | DFNA9 | L | N | ST | 85 | 83.3 | 21.6 | – | 19% | M | 6% | M | 57 | 92 | 86 |
| 8 | M | 69 | DFNA9 | L | N | ST | 80 | 73.3 | 13.3 | 0 | 58% | P | – | – | 24 | 63 | 82 |
| 9 | M | 71 | DFNA9 | L | N | ST | 76.7 | 78.3 | 21.6 | 6.7 | 38% | P | 5% | M | 27 | 80 | 83 |
| 10 | M | 65 | Unknown | R | Y c | ST | 101.7 | 90 | 10 | 13.3 | 0% | M | – | – | 24 | 93 | 93 |
| 11 | M | 70 | DFNA9 | R | N | ST | 88.3 | 75 | 23.4 | 0 | 0% | M | 15% | M | 15 | 74 | 84 |
| 12 | F | 73 | Meniere | R | N | ST | 88.3 | NMH | 23.4 | – | 0% | M | 0% | M | 0 | 79 | 72 |
| 13 | M | 73 | Unknown | L | N | ST | 85 | 85 | 21.67 | 3.33 | 19% | M | 38% | P | 12 | 84 | 82 |
| 14 | F | 67 | Hereditary | L | N | ST | 81.7 | 70 | 3.3 | 1.6 | 89% | C | 78% | C | 38 | - | 59 |
| 15 | F | 69 | Unknown | R | N | ST | 91.7 | 81.7 | 18.3 | – 8.4 | 9% | M | 17% | M | 12 | 89 | 84 |
| 16 | F | 67 | DFNA9 | R | N | ST | 81.7 | 56.7 | 28.3 | 1.6 | 6% | M | 0% | M | 10 | 89 | 95 |
| 17 | M | 76 | Unknown | R | N | ST | 76.7 | 68.3 | 10 | 11.7 | 71% | P | 67% | P | 57 | 60 | 68 |
| 18 | M | 74 | Hereditary | R | N | ST | 80 | 60 | 10 | – 1.7 | 68% | P | 84% | C | 15 | - | 96 |
| 19 | F | 70 | Unknown | L | N | ST | 61.7 | 58.3 | 8.3 | 0 | 83% | C | 80% | C | 36 | 93 | 86 |
| 20 | F | 65 | DFNA9 | L | N | ST | 53.3 | 110 | 35 | – | 40% | P | 57% | P | 51 | 67 | 84 |
| 21 | M | 49 | DFNA9 | R | N | ST | 98.3 | 95 | 1.7 | – 1.7 | 87% | C | – | – | 24 | 66 | - |
| 22 | F | 71 | Unknown | R | N | ST | 93.3 | 78.3 | 16.7 | – 3.3 | 9% | M | 20% | M | 3 | 57 | 86 |
| 23 | M | 80 | Unknown | L | N | ST | 71.7 | 55 | 5 | 0 | 88% | C | 54% | P | 27 | 26 | 55 |
| Mean: | 81.5 | 75.3 | 16.2 | 0.09 | 44% | 37% | 27.1 | 72.1 | 81.1 | ||||||||
LFPTA low frequency pure tone average (average threshold over 250, 500 and 1000 Hz), CL contralateral, dB decibel, RHP relative hearing preservation (defined by Skarzynski et al. [16] using the following formula: NMH non-measurable hearing (defined as a participant without response at maximum stimulation level at two or more frequencies)
aΔ LFPTA = Threshold shift between pre- and post-operative LFPTA (at activation, 2 months post-operatively)
bParticipant 1 was not included in the post-operative speech perception outcome evaluations due to the retro-cochlear etiology of hearing loss
cIn participant 10, an intraoperative tip fold-over occurred and, therefore, the residual hearing data were not included in the average outcomes
Residual hearing outcomes obtained in the current study compared to the results obtained in the previous study by Heutink et al. (CS), as well as specifically for participants in whom the electrode array located in the scala tympani (ST) and those with a translocated electrode array [4]
| eRW (current study) | CS (Heutink et al.) | CS–ST (Heutink et al.) | CS–Translocation (Heutink et al.) | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mean (SD) | Mean (SD) | Mean (SD) | Mean (SD) | ||||||||
| Preoperative LFPTA1 in dB | 81.5 (11.9) | 23 | 92.2 (13.3) | 19 | 94.9 (10.7) | 12 | 87.1 (19) | 7 | 0.296 | ||
| Postoperative threshold shift in LFPTA in dB | 16.2 (10.8) | 22 | 9.2 (9.2) | 17 | 4.4 (5.3) | 11 | 17.9 (9) | 6 | 0.723 | ||
| RHP% as per Skarzynski2 | 43.9 (34.8) | 22 | 56.9 (46.3) | 17 | 0.269 | 77.2 (45) | 11 | 19.8 (16) | 6 | ||
aOne `participant (#10) was excluded from hearing outcome analysis due to a tip fold-over
1Low frequency pure tone average: average threshold for 250, 500 and 1000 Hz
2Residual hearing preservation,
Mean speech perception scores obtained in the current study compared to participants with late onset of hearing loss from the previous study by Heutink et al. (CS), as well as specifically for participants in whom the electrode array located in the scala tympani (CS–ST) and scala vestibuli (CS–SV) [4]
| eRW (Current study) | CS (Heutink et al.) | CS–ST (Heutink et al.) | CS–Translocation (Heutink et al.) | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mean (SD) | Mean (SD) | Mean (SD) | Mean (SD) | ||||||||
| Preoperative CVC-phoneme score (%) | 27.1 (16.9) | 22a | 7.2 (12.9) | 12 | 10.5 (16.5) | 6 | 0.042 | 3.83 (8.0) | 6 | ||
| Postoperative CVC-phoneme score (%) (2-month) | 72.1 (18.0) | 21b | 60.6 (23.4) | 11 | 0.138 | 72.4 (14.3) | 5 | 0.973 | 50.83 (26.0) | 6 | |
| Postoperative CVC-phoneme score (%) (12-month) | 81.1 (11.1) | 21 | 77.6 (15.1) | 8 | 0.496 | 88.3 (10.8) | 4 | 0.251 | 67.0 (10.9) | 4 | |
aPreoperative CVC scores were missing for one participant (#6)
bOne participant (#1) was excluded from post-operative speech perception outcome analysis due to a retro-cochlear etiology of hearing loss and one participant was lost to follow-up (#21)